Feng Wang-Johanning

Title: **Feng Wang-Johanning: Innovator in Immunotherapy**

Introduction

Feng Wang-Johanning is an esteemed inventor based in Bastrop, TX, known for his significant contributions to the field of immunotherapy. With three patents to his name, he is dedicated to advancing cancer treatment through innovative methodologies.

Latest Patents

Wang-Johanning's latest patents focus on the human application of engineered chimeric antigen receptor (CAR) T-cells. The invention outlines methods and compositions for immunotherapy that utilize modified T cells featuring chimeric antigen receptors. Notably, the CAR-expressing T-cells are produced using electroporation in collaboration with a transposon-based integration system. This approach allows for a population of CAR-expressing cells that require minimal ex vivo expansion or can be directly administered to patients for effective disease treatment, particularly in combating cancer.

Career Highlights

As a prominent member of the University of Texas System, Wang-Johanning has built an impressive career at the forefront of cancer research and treatment. His innovative methodologies have garnered attention in both academic and clinical settings, further establishing him as a key player in immunotherapy advancements.

Collaborations

Feng Wang-Johanning collaborates with notable researchers, including Hiroki Torikai and Ling Zhang. Their shared expertise in the field enhances the potential outcomes of their projects, contributing to the cutting-edge developments in CAR T-cell therapies.

Conclusion

Feng Wang-Johanning exemplifies the spirit of innovation in immunotherapy through his patented inventions and collaborative research efforts. His work continues to pave the way for new treatments that can significantly improve patient outcomes in the battle against cancer.